Technology | 2009.10.21
Published Study Demonstrates Clinical Accuracy and Ease of Use of TRUE2go Blood Glucose Monitoring System from Home Diagnostics
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Home Diagnostics, Inc. (NASDAQ:HDIX), a leading developer, manufacturer, and marketer of blood glucose monitoring systems, today announced the results of a TRUE2go™ clinical performance study published in the October 2009 issue of the journal Diabetes Technology & Therapeutics. The study, “Clinical Performance of the TRUE2go Blood Glucose System – A Novel Integrated System for Meter and Strips,” demonstrated the accuracy and pre
For more information, please visit
http://www.businesswire.com/news/home/20091021005140/en
